##gff-version 3
##sequence-region Q96NR8 1 316
Q96NR8	UniProtKB	Chain	1	316	.	.	.	ID=PRO_0000054766;Note=Retinol dehydrogenase 12	
Q96NR8	UniProtKB	Nucleotide binding	46	52	.	.	.	Note=NADP;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q96NR8	UniProtKB	Active site	200	200	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q96NR8	UniProtKB	Binding site	175	175	.	.	.	Note=Substrate;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q96NR8	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_064163;Note=In retinal dystrophy%3B exhibits a profound loss of catalytic activity. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs761231974,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_020858;Note=In LCA13%3B aberrant activity in interconverting isomers of retinol and retinal%3B abolishes protection against the toxicity of 4-hydroxynonenal in the retina%3B there is differing activity profiles associated with each of the alleles of the R-161-Q polymorphism%3B genetic background may act as a modifier of mutation effect. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15258582,ECO:0000269|PubMed:19686838;Dbxref=dbSNP:rs28940314,PMID:15258582,PMID:19686838	
Q96NR8	UniProtKB	Natural variant	51	51	.	.	.	ID=VAR_020859;Note=In LCA13. I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15322982;Dbxref=dbSNP:rs104894473,PMID:15322982	
Q96NR8	UniProtKB	Natural variant	55	55	.	.	.	ID=VAR_064164;Note=In retinal dystrophy%3B exhibits a profound loss of catalytic activity. T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs766631462,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_064165;Note=R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs745471670,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_064166;Note=In RP53. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19956407;Dbxref=dbSNP:rs368489658,PMID:19956407	
Q96NR8	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_067193;Note=Found in a patient with LCA13. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21602930;Dbxref=dbSNP:rs763414313,PMID:21602930	
Q96NR8	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_020860;Note=In LCA13%3B exhibits a profound loss of catalytic activity. L->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15322982,ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs28940315,PMID:15322982,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_064167;Note=D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs148334092,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_064168;Note=In retinal dystrophy%3B exhibits a profound loss of catalytic activity. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=PMID:16269441	
Q96NR8	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_064169;Note=In RP53. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19140180;Dbxref=dbSNP:rs202126574,PMID:19140180	
Q96NR8	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_064170;Note=In retinal dystrophy%3B exhibits a profound loss of catalytic activity. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs907600014,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_081222;Note=In RP53%3B early onset%3B unknown pathological significance. V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26124963;Dbxref=PMID:26124963	
Q96NR8	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_020861;Note=In LCA13%3B exhibits a profound loss of catalytic activity. H->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15322982,ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs104894475,PMID:15322982,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_020862;Note=In LCA13. H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15322982;Dbxref=dbSNP:rs104894475,PMID:15322982	
Q96NR8	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_064171;Note=In retinal dystrophy%3B exhibits a profound loss of catalytic activity. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs121434337,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_028281;Note=Does not affect the protection against the toxicity of 4-hydroxynonenal in the retina. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14702039,ECO:0000269|PubMed:16269441,ECO:0000269|PubMed:19686838,ECO:0000269|PubMed:21602930;Dbxref=dbSNP:rs17852293,PMID:14702039,PMID:16269441,PMID:19686838,PMID:21602930	
Q96NR8	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_020863;Note=In LCA13. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15322982;Dbxref=dbSNP:rs104894472,PMID:15322982	
Q96NR8	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_064172;Note=In retinal dystrophy%3B unknown pathological significance. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs148629905,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_064173;Note=In retinal dystrophy%3B exhibits a profound loss of catalytic activity. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=PMID:16269441	
Q96NR8	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_064174;Note=In retinal dystrophy%3B unknown pathological significance. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs1254096311,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_020864;Note=In LCA13%3B diminished activity in interconverting isomers of retinol and retinal. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15258582;Dbxref=dbSNP:rs28940313,PMID:15258582	
Q96NR8	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_020865;Note=In LCA13. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15322982;Dbxref=dbSNP:rs104894476,PMID:15322982	
Q96NR8	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_064175;Note=In retinal dystrophy%3B unknown pathological significance. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=PMID:16269441	
Q96NR8	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_064176;Note=In retinal dystrophy%3B unknown pathological significance%3B exhibits a loss of catalytic activity. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs750636662,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_064177;Note=In retinal dystrophy%3B exhibits a profound loss of catalytic activity. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs751589863,PMID:16269441	
Q96NR8	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_064178;Note=In retinal dystrophy%3B exhibits a profound loss of catalytic activity. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=PMID:16269441	
Q96NR8	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_064179;Note=In retinal dystrophy%3B exhibits a profound loss of catalytic activity. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16269441;Dbxref=dbSNP:rs973306929,PMID:16269441	
